Study examined minimal residual disease monitoring to help predict early relapse in patients with mantle cell lymphoma.
Home / Resource Library / Noninvasive monitoring of mantle cell lymphoma by immunoglobulin gene next-generation sequencing in a phase 2 study of sequential chemo-radioimmunotherapy followed by autologous stem cell rescue